IGF2 and cancer: The finding that cancer-secreted IGF-II (big-IGF-II) skips the binding control exerted on mature IGF-II by the IGFBPs (as graphically summarized in Figure 2) suggests that more specific targeting strategies should be considered in order to target this factor in its cancer-specific context.